Premier Perspectives

The blog for insider insights in clinical development

Premier Voices Podcast

Conversations with Premier's subject matter experts
PREMIER VOICES #12: Direct-to-Patient – Is This the ‘New Normal’ for Clinical Trials?

PREMIER VOICES #12

Direct-to-Patient – Is This the ‘New Normal’ for Clinical Trials?
PREMIER VOICES #11: Statistical Considerations in the Wake of COVID-19

PREMIER VOICES #11

Statistical Considerations in the Wake of COVID-19
PREMIER VOICES #10: COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster

PREMIER VOICES #10

COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster
PREMIER VOICES #9: COVID-19 Update – What Sponsors Need to Know About the New FDA Guidance

PREMIER VOICES #9

COVID-19 Update – What Sponsors Need to Know About the New FDA Guidance
Premier Voices #8: Engaging Patients in Clinical Trials w/ Alan Thomas & Juliet Moritz

Premier Voices #8

Engaging Patients in Clinical Trials w/ Alan Thomas & Juliet Moritz
Premier Voices #7: Rare Disease Advocacy & International Ataxia Day w/ Alan Thomas (Ataxia & Me)

Premier Voices #7

Rare Disease Advocacy & International Ataxia Day w/ Alan Thomas (Ataxia & Me)
Premier Voices #6: Operationalizing the New MDR With Janet Kube (Part 2)

Premier Voices #6

Operationalizing the New MDR With Janet Kube (Part 2)
Premier Voices #5: Operationalizing the New MDR With Janet Kube (Part 1)

Premier Voices #5

Operationalizing the New MDR With Janet Kube (Part 1)
Premier Voices #4: The Placebo Problem Part 2 With Michael Kuss

Premier Voices #4

The Placebo Problem Part 2 With Michael Kuss
Premier Voices #3: The Placebo Problem Part 1 With Scott Millard

Premier Voices #3

The Placebo Problem Part 1 With Scott Millard

Recent Posts

Learn more about the latest events and updates.